BioCardia Inc.
Last updated September 27, 2026
Organization details
- Legal name
- BioCardia Inc.
- Former names
- Tiger X Medical, Inc. Cardo Medical, Inc. Clicknsettle COM Inc NAM Corp
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Sunnyvale
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BCDA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000925741
- EIN
- 23-2753988
Board of directors
-
Andrew Scott Blank · DirectorSince 2023
-
Bill Facteau · DirectorSince 2023
-
Jay M. Moyes · DirectorSince 2023
-
Jim L. Allen · DirectorSince 2023
-
Krisztina M. Zsebo · DirectorSince 2023
-
Marvin Slosman · DirectorSince 2025
-
Peter Altman · Director · President and CEOSince 2023
-
Richard M. Krasno · DirectorSince 2023
-
Simon H. Stertzer · DirectorSince 2023
Chief executives
Peter Altman
· President and CEO
Dates unknown
Director election results
Annual meeting of December 2, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.7%
-
94.7%
-
94.9%
Board connections
3 of this board's directors also sit on 4 other boards.
- via Marvin Slosman
- via Richard M. Krasno
- via Jay M. Moyes
- via Jay M. Moyes
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $168,160
- 31 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,900 | $1.05 | $1,995 |
| Sep 3, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +800 | $1.09 | $872 |
| Aug 17, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +5,400 | $0.93 | $5,022 |
| Aug 13, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,900 | $0.92 | $1,748 |
| Jul 29, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +5,000 | $0.78 | $3,900 |
| Jul 17, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +500 | $0.83 | $415 |
| Jul 15, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,500 | $0.86 | $1,290 |
| Jul 14, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +2,800 | $0.88 | $2,464 |
| Jul 10, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,000 | $0.94 | $940 |
| Jul 9, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +1,000 | $0.90 | $900 |
| Jul 8, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +5,400 | $0.96 | $5,208 |
| Jul 8, 2026 | Peter Altman Director, Officer (President and CEO) | Open-market purchase | +5,500 | $0.97 | $5,335 |
| Jul 2, 2026 | Peter Altman Director, Officer (President and CEO) | Shares withheld for tax | −54,606 | $1.24 | $67,711 |
| Jul 2, 2026 | GILLIS EDWARD M Officer (Senior Vice President, Devices) | Shares withheld for tax | −17,269 | $1.24 | $21,414 |
| Jul 2, 2026 | McClung David Officer (Chief Financial Officer) | Shares withheld for tax | −23,125 | $1.24 | $28,675 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.